Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in … J Creaney, S Sneddon, IM Dick, H Dare, N Boudville, AW Musk, SJ Skates, ... Disease markers 35, 119-127, 2013 | 38 | 2013 |
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma S Sneddon, JS Leon, IM Dick, G Cadby, N Olsen, F Brims, RJN Allcock, ... Gene 563 (1), 103-105, 2015 | 37 | 2015 |
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma S Sneddon, AM Patch, IM Dick, S Kazakoff, JV Pearson, N Waddell, ... BMC cancer 17, 1-10, 2017 | 34 | 2017 |
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen J Creaney, S Ma, SA Sneddon, MR Tourigny, IM Dick, JS Leon, A Khong, ... Oncoimmunology 4 (7), e1011492, 2015 | 32 | 2015 |
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma J Creaney, AM Patch, V Addala, SA Sneddon, K Nones, IM Dick, YCG Lee, ... Genome Medicine 14 (1), 58, 2022 | 30 | 2022 |
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations S Sneddon, I Dick, YCG Lee, AWB Musk, AM Patch, JV Pearson, ... Lung Cancer 119, 64-70, 2018 | 26 | 2018 |
Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma S Sneddon, CM Rive, S Ma, IM Dick, RJN Allcock, SD Brown, RA Holt, ... Oncoimmunology 9 (1), 1684713, 2020 | 15 | 2020 |
Characterization of the immune cell landscape in CRC: clinical implications of tumour-infiltrating leukocytes in early-and late-stage CRC ZA Bazzi, S Sneddon, PGY Zhang, IT Tai Frontiers in Immunology 13, 978862, 2023 | 7 | 2023 |
The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma N Calvert, J Wu, S Sneddon, J Woodhouse, R Carey-Smith, D Wood, ... Clinical sarcoma research 8, 1-8, 2018 | 4 | 2018 |
BAP1 mutations in mesothelioma: advances and controversies S Sneddon, J Creaney Current Pulmonology Reports 5, 13-19, 2016 | 1 | 2016 |
89P Dissecting tumour-immune interactions in mesothelioma for identifying responders to immune checkpoint blockade V Addala, S Sneddon, I Dick, D Fennell, JV Pearson, B Robinson, ... Annals of Oncology 31, S1453, 2020 | | 2020 |
Molecular characterisation of murine and human malignant mesothelioma and the identification of neoantigens as potential targets for therapy using next generation sequencing S Sneddon | | 2017 |
GENETIC PROFILING OF MALIGNANT MESOTHELIOMA IN PLEURAL EFFUSIONS SHOWS HIGH VARIABILITY S Sneddon, S Brown, R Holt, B Robinson, J Creaney RESPIROLOGY 21, 48-48, 2016 | | 2016 |
Use of Next Generation Sequencing to Improve Lung Tumor Immunotherapy BWS Robinson, S Ma, S Sneddon, MR Tourigny, I Dick, JS Leon, A Khong, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S351-S351, 2015 | | 2015 |
Understanding the Genetic Landscape of Malignant Mesothelioma-A Comparison of Human and Murine Mesothelioma Cell Lines J Creaney, S Sneddon, N Waddell, J Pearson, S Grimmond, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S504-S504, 2015 | | 2015 |
University of Tasmania Open Access Repository Cover sheet AD Lynch Papers and Proceedings of the Royal Society of Tasmania 128, 17, 1994 | | 1994 |
–Whole exome sequencing of a wild-type asbestos-induced murine model of malignant mesothelioma S Sneddon, AM Patch, IM Dick, S Kazakoff, JV Pearson, N Waddell, ... Molecular characterisation of murine and human malignant mesothelioma and …, 0 | | |
Next generation sequencing of pleural effusion tumour cells in malignant mesothelioma identifies novel regions of interest S Sneddon, I Dick, YCG Lee, AWB Musk, N Waddell, AM Patch, ... Molecular characterisation of murine and human malignant mesothelioma and …, 0 | | |
Appendix–Two published papers related to the work in this thesis S Sneddon Molecular characterisation of murine and human malignant mesothelioma and …, 0 | | |